Please login to the form below
AbbVie: UK patients want better arthritis care
Study from Humira manufacturer concludes that UK doctors need better collaboration with patients
Men's oesophageal cancer risk "triple that of women"
New data from Cancer Research UK shines slight on 'quiet epidemic'
FDA approves Sanofi's four-in-one flu vaccine
But wants more safety data for hepatitis B vaccine from Dynavax
Pharmacists lack long-term confidence – survey
Uncertainty over reforms and Category M claw-back to blame for this drop in confidence
Data on diabetes drug links to cancer withheld says investigation
BMJ and Channel 4 say access to raw trial data would help resolve uncertainly about GLP-1 agonists
UK phenome lab opens for business
Was previously used by GSK as doping facility during 2012 Olympics
Big data project could transform health research
Aims to standardise handling of genetic and clinical data
US FDA approves Roche's assay as first blood test to diagnose diabetes
Will help catch diabetes early in country where seven million people are undiagnosed
England to launch 15 networks for NHS to work with academia
NHS England backs Academic Health Science Networks to spread innovation
Restless youth: tomorrow's leaders in healthcare
With the speed and force at which technology is shaping the world of medicine and healthcare, isn’t it time we begin allocating resources to those who can execute these
-
Healthcare 'freakonomics'Understanding the economics of the healthcare market enables us to limit the impact of the system’s inherent failures
-
Pharmaceutical conference to discuss healthcare in the new NHSABPI’s chief executive calls for “bold, provocative ideas” in new UK healthcare landscape
-
Death leads to recall of batch of Takeda's Rienso in SwitzerlandMarketing partner Amag also reports three other hypersensitivity reactions
-
GSK awarded $200m by US government for antibiotic researchFollows state-supported schemes in Europe to combat resistance to antibiotics
-
David Nicholson to step down as head of England’s NHSDecision to retire comes two months after publication of Francis report into hospital scandal
-
Roche repeats cancer drugs warning as Avastin faces another NICE rejectionConcerns about future of Cancer Drugs Fund
-
Italian pharma market set for continued downturnWill fall $1.6bn in value by 2020, says analyst GlobalData
-
India puts cost controls on medicinesDrugs (Prices Control) Order 2013 reduces price of hundreds of drugs
-
Merck & Co and GSK offer discounted cervical vaccines to developing nations
Pharma companies team up with GAVI Alliance to provide Cervarix and Gardasil
-
Former UK health secretary joins Bupa boardPatricia Hewitt will serve private health firm as non-executive director
-
Sir Mike Richards appointed England’s chief inspector of hospitalsHSJ reports that former cancer tsar will become NHS’ 'whistleblower-in-chief'
-
Clare Gerada to step down as UK RCGP chairMaureen Baker nominated as chair-elect
-
Bupa appoints chief risk officerGerry Kelly joins from Lloyds
-
David Haslam takes over as NICE chairReplaces Sir Michael Rawlins as body gains new social care responsibilities
Latest healthcare appointments
Featured jobs
- Head of Commercial Training Strategy (m/ f)
- On application
- Marketing Manager - Pharmaceuticals, Northern UK
- Excellent Salary & Benefits
- UK Marketing Director
- 80,000 to 100,000 per annum
- Medical Writer / Editor – LONDON
- DOE
Subscribe to our email news alerts
- Building BRICs: pharma's key emerging markets are becoming giants
- The hunted now hunt: biotechs become buyers
- Kantar Media and Pointlogic unveil comms planning platform
- AbbVie: UK patients want better arthritis care
- Pay-for-delay deals lead to inflated drug prices says study
- Google 'aiding and abetting' illegal online pharmacies
Latest intelligence
- Building BRICs: pharma's key emerging markets are becoming giants
- The BRIC nations – Brazil, Russia, India and China – for so long the leading lights of the emerging markets movement, may soon need to relinquish their 'emerging' tag and become 'giants'...
- What IF (Indigenus Forum) Meeting Report
- IFs (Indigenus Forums) are a series of invite-only events hosted by Indigenus agencies that bring top thought leaders together to help solve some of our industry’s most pressing challenges. ...
- Developing multichannel capability in Pharma
- Understanding your customers' needs is only half of the multichannel challenge; you must also have the business capability to deliver on your objectives. Find out how training could give your ...
Quick links
